USD 0.35
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 3.13 Million USD | -22.24% |
2023 | 4.03 Million USD | 6.47% |
2022 | 3.78 Million USD | -3.0% |
2021 | 3.9 Million USD | -2.47% |
2020 | 4 Million USD | -14.29% |
2019 | 4.67 Million USD | -6.7% |
2018 | 5 Million USD | 13.64% |
2017 | 4.4 Million USD | -3.74% |
2016 | 4.57 Million USD | -2.49% |
2015 | 4.69 Million USD | 7.15% |
2014 | 4.38 Million USD | -32.97% |
2013 | 6.53 Million USD | -6.98% |
2012 | 7.02 Million USD | -2.61% |
2011 | 7.21 Million USD | -8.31% |
2010 | 7.86 Million USD | -1.25% |
2009 | 7.96 Million USD | 4.79% |
2008 | 7.6 Million USD | 10.11% |
2007 | 6.9 Million USD | 24.19% |
2006 | 5.55 Million USD | 18.98% |
2005 | 4.67 Million USD | 9.14% |
2004 | 4.28 Million USD | 5.96% |
2003 | 4.04 Million USD | 46.49% |
2002 | 2.75 Million USD | 56.46% |
2001 | 1.76 Million USD | 144.43% |
2000 | 721.19 Thousand USD | 61.44% |
1999 | 446.73 Thousand USD | 357.84% |
1998 | 97.57 Thousand USD | 509.61% |
1997 | -23.82 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 863 Thousand USD | -15.23% |
2024 Q3 | 727.23 Thousand USD | -15.63% |
2024 FY | 3.13 Million USD | -22.24% |
2024 Q4 | 646 Thousand USD | -11.17% |
2024 Q2 | 862 Thousand USD | -0.12% |
2023 Q3 | 898 Thousand USD | 7.93% |
2023 FY | 4.03 Million USD | 6.47% |
2023 Q4 | 1.01 Million USD | 13.36% |
2023 Q2 | 832.01 Thousand USD | -35.2% |
2023 Q1 | 1.28 Million USD | 58.91% |
2022 Q1 | 1.02 Million USD | -12.0% |
2022 FY | 3.78 Million USD | -3.0% |
2022 Q4 | 808 Thousand USD | -20.0% |
2022 Q3 | 1.01 Million USD | 6.88% |
2022 Q2 | 945 Thousand USD | -7.98% |
2021 Q1 | 647 Thousand USD | -31.02% |
2021 FY | 3.9 Million USD | -2.47% |
2021 Q2 | 988 Thousand USD | 52.7% |
2021 Q4 | 1.16 Million USD | 5.52% |
2021 Q3 | 1.1 Million USD | 11.94% |
2020 FY | 4 Million USD | -14.29% |
2020 Q4 | 938 Thousand USD | -13.39% |
2020 Q3 | 1.08 Million USD | 3.24% |
2020 Q1 | 933 Thousand USD | -15.41% |
2020 Q2 | 1.04 Million USD | 12.43% |
2019 Q2 | 1.2 Million USD | -7.38% |
2019 FY | 4.67 Million USD | -6.7% |
2019 Q4 | 1.1 Million USD | 3.86% |
2019 Q3 | 1.06 Million USD | -11.87% |
2019 Q1 | 1.3 Million USD | 11.1% |
2018 FY | 5 Million USD | 13.64% |
2018 Q3 | 1.23 Million USD | -1.99% |
2018 Q4 | 1.17 Million USD | -5.11% |
2018 Q2 | 1.25 Million USD | -6.32% |
2018 Q1 | 1.34 Million USD | 17.69% |
2017 Q2 | 1 Million USD | -15.21% |
2017 Q4 | 1.14 Million USD | 7.33% |
2017 FY | 4.4 Million USD | -3.74% |
2017 Q1 | 1.19 Million USD | 13.44% |
2017 Q3 | 1.06 Million USD | 5.45% |
2016 Q2 | 1.18 Million USD | 0.51% |
2016 FY | 4.57 Million USD | -2.49% |
2016 Q4 | 1.04 Million USD | -10.65% |
2016 Q3 | 1.17 Million USD | -0.51% |
2016 Q1 | 1.17 Million USD | -0.59% |
2015 Q4 | 1.18 Million USD | -2.88% |
2015 FY | 4.69 Million USD | 7.15% |
2015 Q1 | 1.22 Million USD | 1227.9% |
2015 Q2 | 1.07 Million USD | -12.03% |
2015 Q3 | 1.21 Million USD | 13.12% |
2014 Q1 | 1.52 Million USD | 1.26% |
2014 Q3 | 1.42 Million USD | 1.21% |
2014 Q2 | 1.4 Million USD | -7.92% |
2014 FY | 4.38 Million USD | -32.97% |
2014 Q4 | 92.02 Thousand USD | -93.54% |
2013 Q3 | 1.66 Million USD | 3.35% |
2013 Q1 | 1.74 Million USD | -9.84% |
2013 Q2 | 1.61 Million USD | -7.78% |
2013 FY | 6.53 Million USD | -6.98% |
2013 Q4 | 1.5 Million USD | -9.42% |
2012 Q1 | 1.77 Million USD | 3.82% |
2012 Q4 | 1.93 Million USD | 11.36% |
2012 Q2 | 1.56 Million USD | -11.97% |
2012 Q3 | 1.74 Million USD | 11.16% |
2012 FY | 7.02 Million USD | -2.61% |
2011 Q4 | 1.71 Million USD | -5.9% |
2011 Q1 | 1.84 Million USD | -1.96% |
2011 FY | 7.21 Million USD | -8.31% |
2011 Q3 | 1.82 Million USD | -0.71% |
2011 Q2 | 1.83 Million USD | -0.55% |
2010 FY | 7.86 Million USD | -1.25% |
2010 Q1 | 2.03 Million USD | 3.12% |
2010 Q2 | 1.94 Million USD | -4.28% |
2010 Q3 | 2 Million USD | 3.27% |
2010 Q4 | 1.88 Million USD | -6.34% |
2009 Q2 | 2.05 Million USD | 10.08% |
2009 Q4 | 1.97 Million USD | -5.24% |
2009 Q1 | 1.86 Million USD | -7.72% |
2009 FY | 7.96 Million USD | 4.79% |
2009 Q3 | 2.07 Million USD | 1.32% |
2008 Q1 | 1.62 Million USD | -7.85% |
2008 Q4 | 2.02 Million USD | -0.35% |
2008 Q3 | 2.02 Million USD | 5.28% |
2008 Q2 | 1.92 Million USD | 18.28% |
2008 FY | 7.6 Million USD | 10.11% |
2007 Q3 | 1.73 Million USD | 2.0% |
2007 Q2 | 1.69 Million USD | -0.4% |
2007 FY | 6.9 Million USD | 24.19% |
2007 Q4 | 1.76 Million USD | 1.97% |
2007 Q1 | 1.7 Million USD | 11.29% |
2006 Q1 | 1.38 Million USD | 8.42% |
2006 Q4 | 1.53 Million USD | 21.12% |
2006 Q3 | 1.26 Million USD | -8.09% |
2006 Q2 | 1.37 Million USD | -0.55% |
2006 FY | 5.55 Million USD | 18.98% |
2005 Q1 | 1.01 Million USD | -11.25% |
2005 Q3 | 1.18 Million USD | -0.94% |
2005 Q2 | 1.19 Million USD | 17.66% |
2005 FY | 4.67 Million USD | 9.14% |
2005 Q4 | 1.27 Million USD | 7.84% |
2004 Q4 | 1.14 Million USD | 8.1% |
2004 FY | 4.28 Million USD | 5.96% |
2004 Q3 | 1.05 Million USD | -4.36% |
2004 Q2 | 1.1 Million USD | 14.16% |
2004 Q1 | 969.93 Thousand USD | -10.61% |
2003 Q3 | 1.05 Million USD | -0.95% |
2003 Q2 | 1.06 Million USD | 28.79% |
2003 FY | 4.04 Million USD | 46.49% |
2003 Q1 | 829.33 Thousand USD | -0.24% |
2003 Q4 | 1.08 Million USD | 2.56% |
2002 Q2 | 738 Thousand USD | 33.32% |
2002 Q1 | 553.55 Thousand USD | -10.53% |
2002 Q3 | 635.14 Thousand USD | -13.94% |
2002 Q4 | 831.36 Thousand USD | 30.89% |
2002 FY | 2.75 Million USD | 56.46% |
2001 FY | 1.76 Million USD | 144.43% |
2001 Q4 | 618.7 Thousand USD | 18.63% |
2001 Q3 | 521.55 Thousand USD | 42.22% |
2001 Q2 | 366.72 Thousand USD | 48.19% |
2001 Q1 | 247.46 Thousand USD | 90.79% |
2000 Q3 | 226.48 Thousand USD | 0.0% |
2000 Q4 | 129.7 Thousand USD | -42.73% |
2000 FY | 721.19 Thousand USD | 61.44% |
1999 FY | 446.73 Thousand USD | 357.84% |
1998 FY | 97.57 Thousand USD | 509.61% |
1997 FY | -23.82 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Medical Technologies Inc. | 1.69 Million USD | -84.565% |
Ansell Limited | 624.8 Million USD | 99.498% |
Ansell Limited | 624.8 Million USD | 99.498% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 113.94 Million USD | 97.248% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 135.05 Thousand USD | -2221.989% |
Psykey, Inc. | 415.97 Thousand USD | -653.881% |
ConvaTec Group Plc | 1.2 Billion USD | 99.739% |
ConvaTec Group Plc | 1.17 Billion USD | 99.733% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 794.01 Thousand USD | -294.951% |
LifePoint, Inc. | -71.35 Thousand USD | 4494.689% |
Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 2493.864% |
Paradigm Medical Industries, Inc. | 525 Thousand USD | -497.326% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 603.24 Thousand USD | -419.853% |
Reflect Scientific, Inc. | 596.42 Thousand USD | -425.797% |
SmileDirectClub, Inc. | 275.84 Million USD | 98.863% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 99.652% |
SheerVision, Inc. | 2.17 Million USD | -44.122% |
United Health Products, Inc. | -4857.00 USD | 64665.823% |
Vasamed, Inc. | -69.38 Thousand USD | 4619.459% |
Wearable Health Solutions, Inc. | 267.66 Thousand USD | -1071.608% |
Yubo International Biotech Limited | 52.65 Thousand USD | -5856.017% |